NCT04096638
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1
Drug Category: Therapeutic Antibody, Immunotherapy
Key Eligibility Criteria:
Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases:
Additional Notes: TNBC patients are only eligible for the expansion phase
Exclusions: Patients with untreated unstable brain metastases- see trial for details
https://ClinicalTrials.gov/show/NCT04096638